SEC Comment Letter for Miluna Acquisition Corp (MMTX, MMTXU, MMTXW) (CIK 0002077033) (MMTX) — Sep 24, 2025
Miluna Acquisition Corp (MMTX, MMTXU, MMTXW) (CIK 0002077033)
Date: Sept. 24, 2025 · CIK: 0002077033 · Accession: 0000000000-25-010421
AI Filing Summary & Sentiment
File numbers found in text: 333-289973
Show Raw Text
September 24, 2025
Shang Ju Lin
Chief Executive Officer
Miluna Acquisition Corp
12F, No. 43, Sec. 4
Cheng Kong Road
Taipei, Taiwan
Re:Miluna Acquisition Corp
Amendment No. 1 to Registration Statement on Form S-1
Filed September 16, 2025
File No. 333-289973
Dear Shang Ju Lin:
We have reviewed your amended registration statement and have the following
comment.
Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our September 12, 2025
letter.
Amendment No. 1 to Form S-1
Our warrant agreement provides a choice of forum provision that may limit a warrant holder's
ability to bring a claim..., page 49
We note your response to prior comment three and reissue the comment. Specifically,
we note your statement "Section 22 of the Securities Act creates concurrent
jurisdiction for state and federal courts over all suits brought to enforce any duty or
liability created by the Securities Act or the rules and regulations thereunder. As a
result, a court could determine that our exclusive forum provision is unenforceable
with respect to such claims and investors will not be deemed to have waived
compliance with the federal securities laws and rules and regulations promulgated 1.
September 24, 2025
Page 2
thereunder." Given that Section 9.3 of your Form of Warrant Agreement provides that
any action under the agreement, including any action arising under the Securities Act
can be brought and enforced in the courts of the State of New York or the U.S.
District Court for the Southern District of New York, please explain the nature of the
uncertainty with respect to the enforceability of the provision, as the provision
specifically provides for concurrent federal and state jurisdiction.
Please contact Tracie Mariner at 202-551-3744 or Sasha Parikh at 202-551-3627 if
you have questions regarding comments on the financial statements and related
matters. Please contact Lauren Hamill at 303-844-1008 or Suzanne Hayes at 202-551-3675
with any other questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Sally Yin